In May 2025, the Trump Administration renewed the idea of international reference pricing through an executive order entitled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients”, which, among other things, directs the U.S. Department of Health and Human Services (“HHS”) and other agencies to communicate most-favored-nation price targets to pharmaceutical manufacturers to bring prices for U.S. patients in line with comparably developed nations and to facilitate direct-to-consumer purchasing programs.
All entries for: Cytokinetics Inc
November 5, 2025
Cytokinetics Inc
Negative Outlook
South San Francisco, CA
501-1,000 employees
We cannot predict the likelihood, nature, or extent of health reform initiatives that may arise from future legislation or administrative action, including most favored nation pricing, for example, and cannot predict the effect of any of such initiatives on our future financial results or the value of our common stock.